Veronica Loy, DO
Hepatology · Chicago, ILNPI 1972780013
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $65,990 of the $77,705 with a category attached, or 84.9%. Gilead accounts for 68.9% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $29,261, more than ten times the $1,450 reported in 2020. Among hepatology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 68 payments — averaging $1142.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$54K
- Intercept Pharmaceuticals, Inc.$20K
- Transmedics, Inc.$3K
- Ipsen Biopharmaceuticals, Inc$335
- AstraZeneca$215
- Fujifilm Healthcare Americas Corporation$98
- plus $25 from 1 others
Across 1 payment — averaging $3000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Transmedics, Inc.$3K
What the payments were for
- Consulting fees$4,0805%
- Speaking & faculty fees$65,99085%
- Travel & lodging$5,2577%
- Food & beverage$2,2773%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 43 | $53,558 |
| Intercept Pharmaceuticals, Inc. | 17 | $20,473 |
| Transmedics, Inc. | 1 | $3,000 |
| Ipsen Biopharmaceuticals, Inc | 2 | $335 |
| AstraZeneca | 3 | $215 |
| Fujifilm Healthcare Americas Corporation | 1 | $98 |
| Celltrion USA Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$77,705 in reported general payments places this provider in the 95th percentile of 21 hepatology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 38 | $122,884 |
| Ursodiol | 68 | $12,521 |
| Tacrolimus | 48 | $5,674 |
| Mycophenolate Mofetil | 18 | $1,882 |
| Lactulose | 19 | $749 |
| Azathioprine | 19 | $576 |
| Famotidine | 28 | $370 |
| Pantoprazole Sodium | 33 | $323 |
| Carvedilol | 30 | $225 |
| Gabapentin | 17 | $196 |
| Spironolactone | 33 | $189 |
| Furosemide | 32 | $170 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 12 | $170 |
| Omeprazole | 13 | $133 |
| Prednisone | 22 | $107 |
Paid to pharmacies, not to this prescriber.
Other hepatology in Chicago
- Sean KoppeChicago$152K
- Amanda CheungChicago$64K
- Daniel GangerChicago$58K
- Christopher MooreChicago$57K
- Justin BoikeChicago$24K
- Andres DuarteChicago$11K
- Anna PatelChicago$6K
- Sarang ThakerChicago$6K
- Sheila EswaranChicago$1K
- Sonu DhillonChicago$995
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.